文献速递神经康复

卒中后多技术小组康复增加训练剂量的临床可行性研究

A technology-enriched approach to increasing rehabilitation dose after stroke: Clinical feasibility study.
PubMed 文献 · Clin Rehabil · 2025-04-18

本研究采用混合方法设计,纳入60例卒中后中位9.0天、转介康复且无轻度运动禁忌的患者,评估多技术小组康复附加常规护理的可行性。结果显示招募率6例/月、脱落率2%、无疑似意外严重不良反应、肩痛发生率19%,临床团队认为可接受,功能评分改善,支持未来开展进一步试验。

要点

  • 卒中后早期多技术小组康复招募率高、脱落率低、安全性好。
  • 肩痛发生率19%,低于预设60%的可行性阈值。
  • 临床团队认为干预可接受,但组织安排限制更高训练剂量。

核心结论

  • 多技术小组康复在卒中后早期增加康复剂量方面显示出良好的可行性,支持未来开展进一步试验。

研究设计与样本

  • 混合方法设计,报告招募、脱落、安全性、剂量和可接受性;纳入60例卒中后中位9.0天(IQR 12.8)转介康复且无轻度运动禁忌的患者。

主要发现

  • 招募率为6例/月,脱落率2%,无疑似意外严重不良反应,肩痛发生率为19%。
  • 临床团队(n=9)访谈主题分析认为干预可接受,并指出组织性限制影响更高剂量。
  • 参与者在住院期间(23.0天,SD 19.7)平均参加9.1次(范围1-32)训练,每次平均52分钟(SD 15.7)。
  • 改良Rivermead移动指数平均提高17.9分(SD 8.6),疗效结局指标平均提高5.7分(SD 2.4)。

关键数值与推荐

  • 可行性基于达到招募率超过3.2例/月、脱落率低于6%、无疑似意外严重不良反应和肩痛发生率低于60%。

临床怎么用

  • 卒中后早期可考虑在常规护理基础上开展多技术小组康复,但需关注组织安排对训练剂量的限制。

局限性

  • 原文未报告研究局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ObjectiveTo assess the feasibility of a multi-technology, group based, approach to increasing rehabilitation dose early after stroke.MethodsMixed methods design reporting recruitment, dropout, safety, dose and acceptability.SettingAcute Hospital Stroke UnitParticipantsSixty stroke patients, 9.0 median (IQR 12.8) days after stroke, referred for rehabilitation, without contraindications to light exercise.InterventionPersonalised rehabilitation delivered in supervised groups, using a multi-technology rehabilitation gym, in addition to usual care.Main measuresFeasibility was based on achieving recruitment rates over 3.2 per month, dropout rates below 6%, absence of suspected unexpected serious adverse reactions and shoulder pain prevalence below 60%. Acceptability was derived from interviews with the clinical team. Dose (rehabilitation time) was recorded manually. Function was measured with the modified Rivermead Mobility Index and Therapy Outcome Measure.ResultsFeasibility was satisfactory with high recruitment rates (6 per month), low dropout (2%), no suspected unexpected serious adverse reactions and low prevalence (19%) of shoulder pain. Thematic analysis of interview data indicated the clinical team (n = 9) found the intervention acceptable and identified organisational constraints to higher doses. Participants attended an average of 9.1 (1-32) sessions during their hospital stay (23.0 days, SD 19.7), with sessions lasting 52 min (SD 15.7), on average. The modified Rivermead Mobility Index and Therapy Outcome Measure increased by 17.9 (SD 8.6) and 5.7 points (SD 2.4), respectively.ConclusionsStrong feasibility findings support future trials of multi-technology, group-based rehabilitation. This novel approach is an encouraging step toward achieving recommended doses of rehabilitation after stroke but needs further investigation.

来源:Clin Rehabil,查看原文。版权归原作者所有。

引用

  1. Sweeney G, Boyd F, Keogh M, et al. A technology-enriched approach to increasing rehabilitation dose after stroke: Clinical feasibility study. Clin Rehabil. 2025. PMID: 40247700. doi:10.1177/02692155251333542

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。